[Chemotherapy in hormone refractory prostatic carcinoma].
Biedermann
B
B
Abteilung für Onkologie, Kantonsspital, Basel.
Pless
M
M
Herrmann
R
R
D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
D000726:Androgen Antagonists; D000970:Antineoplastic Agents
Chemotherapie beim hormonrefraktären Prostatakarzinom.